- Home
- XBP vs INCR Comparison
XBP vs INCR Comparison
Compare XBP & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- INCR
- Stock Information
- Founded
- XBP 2020
- INCR 1994
- Country
- XBP United States
- INCR Israel
- Employees
- XBP N/A
- INCR 320
- Industry
- XBP Business Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- INCR Health Care
- Exchange
- XBP Nasdaq
- INCR Nasdaq
- Market Cap
- XBP 75.2M
- INCR 82.3M
- IPO Year
- XBP N/A
- INCR N/A
- Fundamental
- Price
- XBP $0.52
- INCR $1.48
- Analyst Decision
- XBP
- INCR
- Analyst Count
- XBP 0
- INCR 0
- Target Price
- XBP N/A
- INCR N/A
- AVG Volume (30 Days)
- XBP 738.5K
- INCR 134.4K
- Earning Date
- XBP 11-11-2025
- INCR 10-08-2025
- Dividend Yield
- XBP N/A
- INCR N/A
- EPS Growth
- XBP N/A
- INCR N/A
- EPS
- XBP N/A
- INCR N/A
- Revenue
- XBP $148,332,000.00
- INCR $72,158,312.00
- Revenue This Year
- XBP N/A
- INCR $69.54
- Revenue Next Year
- XBP N/A
- INCR $41.75
- P/E Ratio
- XBP N/A
- INCR N/A
- Revenue Growth
- XBP 0.23
- INCR N/A
- 52 Week Low
- XBP $0.42
- INCR $1.17
- 52 Week High
- XBP $2.56
- INCR $1.82
- Technical
- Relative Strength Index (RSI)
- XBP 34.73
- INCR 41.77
- Support Level
- XBP $0.46
- INCR $1.42
- Resistance Level
- XBP $0.56
- INCR $1.65
- Average True Range (ATR)
- XBP 0.07
- INCR 0.08
- MACD
- XBP -0.01
- INCR -0.02
- Stochastic Oscillator
- XBP 19.93
- INCR 23.08
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.